Literature DB >> 1354033

Pharmacological profile of the atypical neuroleptic sertindole.

J Hyttel1, J Arnt, B Costall, A Domeney, N Dragsted, H L Lembøl, E Meier, R J Naylor, G Nowak, C Sánchez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1354033     DOI： 10.1097/00002826-199201001-00139

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN： 0362-5664            Impact factor:   1.592


× No keyword cloud information.
  5 in total

1.  Clinical observations of sertindole in 53 hospitalised patients with psychotic disorders.

Authors:  Tilman Steinert; Barbara Hauger; Jürgen Eckardt; Peter Schmid
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

Review 2.  Measuring the costs of schizophrenia. Implications for the post-institutional era in the US.

Authors:  K G Terkelsen; A Menikoff
Journal:  Pharmacoeconomics       Date:  1995-09       Impact factor: 4.981

Review 3.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

4.  Emerging role of sertindole in the management of schizophrenia.

Authors:  Stephanie L Cincotta; Joshua S Rodefer
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

5.  Evaluation of patients on sertindole treatment after failure of other antipsychotics: a retrospective analysis.

Authors:  Jean-Michel Azorin; Susana Murteira; Karina Hansen; Mondher Toumi
Journal:  BMC Psychiatry       Date:  2008-03-14       Impact factor: 3.630
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.